Waste product that can indicate gout or kidney issues
15 of 22 providers
Metabolic Health / Glucose
metabolic syndrome
Uric acid is the end product of purine metabolism. Purines are nitrogen-containing compounds found in DNA, RNA, and certain foods (red meat, organ meats, seafood, alcohol). When cells break down or you consume purine-rich foods, purines are metabolized to uric acid, which is then excreted by the kidneys (70%) and gut (30%). Elevated uric acid (hyperuricemia) is best known for causing gout—painful crystallization of uric acid in joints—but it's also a powerful independent risk factor for metabolic syndrome, hypertension, kidney disease, cardiovascular disease, and all-cause mortality.
Here's the critical insight:uric acid is not just a byproduct—it's an active signaling molecule that drives metabolic dysfunction. High uric acid (>5.5 mg/dL) impairs nitric oxide production (worsening endothelial function and raising blood pressure), activates the NLRP3 inflammasome (promoting inflammation), stimulates fat storage in the liver (causing fatty liver), and worsens insulin resistance. Uric acid is a CAUSE, not just a marker, of metabolic disease. Lowering uric acid with diet, weight loss, or allopurinol improves blood pressure, insulin sensitivity, and cardiovascular outcomes.
Standard "normal"ranges for uric acid (3.5-7.2 mg/dL men, 2.6-6.0 mg/dL women) are far too high. For longevity optimization, target <5.5 mg/dL (ideally 4-5 mg/dL). Uric acid >5.5 mg/dL is associated with doubling of hypertension risk, 40% higher kidney disease risk, and 20-30% higher CVD mortality. Even within the "normal"range, lower is better for metabolic health.
| Range Type | Level | Significance |
|---|---|---|
| Optimal (Longevity) | 3.5-5.0 mg/dL | Target for optimal metabolic health, blood pressure, and longevity. Lower uric acid within this range associated with lowest CVD and kidney disease risk. |
| Acceptable | 5.0-5.5 mg/dL | Upper end of optimal. Acceptable for most people but consider lifestyle optimization if trending upward. |
| Suboptimal (Elevated) | 5.5-7.0 mg/dL | Increased risk of hypertension (2x), metabolic syndrome, kidney disease. Intervene with diet, weight loss, hydration. Consider allopurinol if >6.5 mg/dL. |
| High (Hyperuricemia) | 7.0-9.0 mg/dL | Frank hyperuricemia. High risk of gout attacks (20-30% will develop gout). Significantly increased CVD and kidney disease risk. Requires uric acid-lowering therapy (allopurinol or febuxostat). |
>9.0 mg/dL
Low (Rare)
Low uric acid is rare. May indicate SIADH (syndrome of inappropriate ADH secretion), Fanconi syndrome (kidney tubular defect), or xanthinuria (rare genetic disorder). Generally not harmful.
Limit high-purine foods:Red meat (beef, lamb, pork), organ meats (liver, kidney), shellfish (shrimp, lobster, mussels), sardines, anchovies, mackerel. Reducing intake lowers uric acid by 0.5-1.0 mg/dL.
Avoid beer and spirits:Alcohol (especially beer) significantly raises uric acid by increasing production and decreasing excretion. Beer contains purines from yeast. Limit to ≤1 drink/day or avoid.
Moderate seafood:Salmon, tuna are lower in purines than shellfish but still contribute. Limit to 2-3x/week.
Fructose is THE dietary driver of uric acid production. Fructose metabolism in the liver generates uric acid as a byproduct (ATP depletion → AMP → uric acid).
Eliminate sugary drinks:Soda, fruit juice, sweetened beverages. Each daily serving of sugar-sweetened beverage raises uric acid by 0.3-0.5 mg/dL and increases gout risk by 75%.
Limit high-fructose corn syrup:Found in processed foods, desserts, sweetened yogurt.
Whole fruit is OK:Fiber in whole fruit mitigates fructose's uric acid-raising effect. Berries, cherries (especially tart cherries) may even lower uric acid.
Low uric acid (<2.5 mg/dL) is rare and usually benign. May indicate:|SIADH (syndrome of inappropriate ADH):Dilutional hyponatremia and low uric acid.|Fanconi syndrome:Kidney tubular defect causing wasting of uric acid, glucose, amino acids, phosphate.|Xanthinuria:Rare genetic xanthine oxidase deficiency. Uric acid very low, xanthine high. Can cause xanthine kidney stones.|Wilson disease:Copper accumulation in liver causes Fanconi-like kidney defect with low uric acid.
Source:Low uric acid is rarely harmful unless due to underlying kidney or metabolic disorder.
leukemia
Source:lymphoma
Kidney disease causing uric acid wasting (Fanconi syndrome, proximal tubular defects).|Medications:Allopurinol, febuxostat (xanthine oxidase inhibitors), probenecid, losartan.|SIADH:Dilutional hyponatremia lowers uric acid.|Genetic:Xanthinuria (xanthine oxidase deficiency).|Low-purine diet:Vegetarian/vegan diet with minimal fructose (rare to cause clinical low uric acid).
Source:Baseline:Check uric acid if gout, kidney stones, hypertension, metabolic syndrome, or obesity.|After lifestyle intervention:Retest 3-6 months after dietary changes (reduce purines, eliminate fructose/alcohol), weight loss, increased hydration. Expect 0.5-2 mg/dL drop with successful intervention. Goal:<5.5 mg/dL (ideally 4-5 mg/dL).|If starting allopurinol/febuxostat:Retest after 4-6 weeks, then every 3 months until uric acid <6 mg/dL (goal <5 mg/dL for gout patients). Adjust dose as needed.|Annual screening:For patients with hypertension, CKD, metabolic syndrome, or history of gout.|If active gout:During acute attack, uric acid may paradoxically be normal or low (inflammation drives uric acid into tissues). Retest 2-4 weeks after attack resolves.
Uric acid >5.5 mg/dL is associated with 2x higher risk of developing hypertension. Uric acid inhibits nitric oxide production (causing vasoconstriction) and activates renin-angiotensin system (sodium retention). Allopurinol (uric acid-lowering drug) reduces systolic BP by 5-10 mmHg in hypertensive patients with hyperuricemia.
Source:Feig DI, et al. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension. JAMA. 2008;300(8):924-932.
Meta-analyses show each 1 mg/dL increase in uric acid associated with 20% higher CVD mortality and 15% higher all-cause mortality. Uric acid >6 mg/dL independently predicts heart attacks, stroke, and heart failure. Uric acid promotes endothelial dysfunction, inflammation, and atherosclerosis.
Source:Kim SY, et al. Hyperuricemia and coronary heart disease:a systematic review and meta-analysis. Arthritis Care Res. 2010;62(2):170-180.
| Provider | Includes | Annual Cost | Biomarkers |
|---|---|---|---|
| ✓ | $199 | 100+ (150 with ratios) | |
| ✓ | $349 | 65 | |
| ✓ | $398 | 30+ | |
| ✓ | $486 | 40+ | |
| — | $468 | 83 | |
| ✓ | $349 | 100+ | |
| — | $680 | 54 | |
| ✓ | $365 | 100+ | |
| ✓ | $250 | 65 | |
| ✓ | $495 | 70+ | |
| ✓ | $895 | 100+ | |
| ✓ | $1950 | 150+ | |
| — | $399 | 100+ | |
| — | $Varies | 75+ | |
| ✓ | $190 | 100+ | |
| — | $99 | 50 | |
| — | $125 | 60 | |
| — | $199 | 50 | |
| ✓ | $499 | 120+ | |
| ✓ | $4188 | 80+ | |
| — | $375 | 85 | |
| ✓ | $700 | 129 |
15 providers include this biomarker in their panels
This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider about your specific health needs.